| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M Vanvuchelen, H Feys, W De Weerd. Is the good-imitator-poor-talker profile syndrome-specific in Down syndrome?: evidence from standardised imitation and language measures. Research in developmental disabilities. vol 32. issue 1. 2011-03-25. PMID:20926249. |
twenty children with down syndrome (ds; mean nonverbal mental age nma 1 y10 m) and 15 children with non-specific mental retardation (ns-mr; mean nma 1 y11 m) participated in this study. |
2011-03-25 |
2023-08-12 |
Not clear |
| Chiara Rigoldi, Manuela Galli, Luca Mainardi, Marcello Crivellini, Giorgio Albertin. Postural control in children, teenagers and adults with Down syndrome. Research in developmental disabilities. vol 32. issue 1. 2011-03-25. PMID:20933364. |
the goal of this work was to analyze postural control in down syndrome (ds) participants considering three different groups composed by children, teenagers and adults with ds. |
2011-03-25 |
2023-08-12 |
human |
| Chiara Rigoldi, Manuela Galli, Luca Mainardi, Marcello Crivellini, Giorgio Albertin. Postural control in children, teenagers and adults with Down syndrome. Research in developmental disabilities. vol 32. issue 1. 2011-03-25. PMID:20933364. |
in particular, cop medio-lateral range of motion pointed out a decrease for both groups considered (pathological and control) in time domain analysis that could lead to the same conclusion in developing strategies, but frequency domain analysis evidenced how this result is reached by the different population: ds people showed a larger frequency of movement in ml more evidenced in adults group (down syndrome adults group vs. |
2011-03-25 |
2023-08-12 |
human |
| Chiara Rigoldi, Manuela Galli, Giorgio Albertin. Gait development during lifespan in subjects with Down syndrome. Research in developmental disabilities. vol 32. issue 1. 2011-03-25. PMID:20943345. |
32 individuals suffering from down syndrome (ds) were enrolled in this study as group of pathological participants. |
2011-03-25 |
2023-08-12 |
human |
| Yee-Pay Wuang, Ching-Sui Chiang, Chwen-Yng Su, Chih-Chung Wan. Effectiveness of virtual reality using Wii gaming technology in children with Down syndrome. Research in developmental disabilities. vol 32. issue 1. 2011-03-25. PMID:21071171. |
this quasi-experimental study compared the effect of standard occupational therapy (sot) and virtual reality using wii gaming technology (vrwii) on children with down syndrome (ds). |
2011-03-25 |
2023-08-12 |
human |
| Lucia Migliore, Fabio Coppedè, Michael Fenech, Philip Thoma. Association of micronucleus frequency with neurodegenerative diseases. Mutagenesis. vol 26. issue 1. 2011-03-25. PMID:21164187. |
studies in other neurodegenerative diseases are largely missing, and some data in premature ageing disorders characterised by neurodegeneration and/or neurological complications, such as ataxia telangiectasia, werner's syndrome, down's syndrome (ds) and cockayne's syndrome, indicate that mni increase with ageing in cultured cells. |
2011-03-25 |
2023-08-12 |
human |
| Ana C Xavier, Yubin Ge, Jeffrey Tau. Unique clinical and biological features of leukemia in Down syndrome children. Expert review of hematology. vol 3. issue 2. 2011-03-22. PMID:21083461. |
acute leukemias in children with down syndrome (ds) are characterized by unique clinical and biological features. |
2011-03-22 |
2023-08-12 |
Not clear |
| Tao Yu, Chunhong Liu, Pavel Belichenko, Steven J Clapcote, Shaomin Li, Annie Pao, Alexander Kleschevnikov, Allison R Bechard, Suhail Asrar, Rongqing Chen, Ni Fan, Zhenyu Zhou, Zhengping Jia, Chu Chen, John C Roder, Bin Liu, Antonio Baldini, William C Mobley, Y Eugene Y. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain research. vol 1366. 2011-03-21. PMID:20932954. |
as the genomic basis for down syndrome (ds), human trisomy 21 is the most common genetic cause of intellectual disability in children and young people. |
2011-03-21 |
2023-08-12 |
mouse |
| A González-Agüero, G Vicente-Rodríguez, L A Moreno, M Guerra-Balic, I Ara, J A Casajú. Health-related physical fitness in children and adolescents with Down syndrome and response to training. Scandinavian journal of medicine & science in sports. vol 20. issue 5. 2011-03-16. PMID:20456681. |
information about physical fitness in the down syndrome (ds) population, however, is scarce, especially when we consider children and adolescents. |
2011-03-16 |
2023-08-12 |
Not clear |
| Priya S Kishnani, James H Heller, Gail A Spiridigliozzi, Ira Lott, Luis Escobar, Sharon Richardson, Richard Zhang, Thomas McRa. Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17. American journal of medical genetics. Part A. vol 152A. issue 12. 2011-03-15. PMID:21108390. |
the objective of this 10-week, randomized, double-blind, placebo-controlled multicenter study was to assess the efficacy and safety of donepezil for the treatment of cognitive dysfunction exhibited by children with down syndrome (ds). |
2011-03-15 |
2023-08-12 |
human |
| Eyby Leon, Ying S Zou, Jeff M Milunsk. Mosaic Down syndrome in a patient with low-level mosaicism detected by microarray. American journal of medical genetics. Part A. vol 152A. issue 12. 2011-03-15. PMID:21108401. |
down syndrome (ds) is the most common aneuploidy in liveborns with an estimated frequency of 1 in 650-1,000 births. |
2011-03-15 |
2023-08-12 |
Not clear |
| James L Kalabus, Carrie C Sanborn, Raqeeb G Jamil, Qiuying Cheng, Javier G Blanc. Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome. Drug metabolism and disposition: the biological fate of chemicals. vol 38. issue 12. 2011-03-14. PMID:20729274. |
cancer patients with down syndrome (ds) are susceptible to developing anthracycline-related cardiotoxicity. |
2011-03-14 |
2023-08-12 |
Not clear |
| Jean Gekas, Audrey Durand, Emmanuel Bujold, Maud Vallée, Jean-Claude Forest, François Rousseau, Daniel Reinhar. Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used? American journal of obstetrics and gynecology. vol 204. issue 2. 2011-03-14. PMID:21074138. |
we analyzed the cost-effectiveness (ce) and performances of commonly used prenatal down syndrome (ds) screening strategies. |
2011-03-14 |
2023-08-12 |
Not clear |
| b' M V Llorens-Mart\\xc3\\xadn, N Rueda, G S Tejeda, J Fl\\xc3\\xb3rez, J L Trejo, C Mart\\xc3\\xadnez-Cu\\xc3\\xa. Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome. Neuroscience. vol 171. issue 4. 2011-03-10. PMID:20875841.' |
the ts65dn (ts) mouse is the most widely used model of down syndrome (ds). |
2011-03-10 |
2023-08-12 |
mouse |
| Kuri Suzuki, Koichi Nakajima, Shuichi Kamimura, Keiichirou Takasugi, Yasuyuki Suzuki, Hideaki Sekine, Nobuhisa Ishi. Eight case reports on sex-hormone profiles in sexually mature male Down syndrome. International journal of urology : official journal of the Japanese Urological Association. vol 17. issue 12. 2011-03-10. PMID:20973837. |
down syndrome (ds) is a congenital disorder usually caused by an extra copy of chromosome 21. |
2011-03-10 |
2023-08-12 |
human |
| Lina Ji, Ved Chauhan, Pankaj Mehta, Jerzy Wegiel, Sangita Mehta, Abha Chauha. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects. Journal of Alzheimer's disease : JAD. vol 22. issue 2. 2011-03-09. PMID:20847428. |
in this study, we report that gelsolin is cleaved in the brains of adult individuals (age, 43-63 years) with down syndrome (ds), and that levels of gelsolin-ctf are significantly increased in the frontal cortex of adult ds subjects as compared to age-matched control subjects. |
2011-03-09 |
2023-08-12 |
human |
| M P H Koster, J L A Pennings, S Imholz, W Rodenburg, G H A Visser, A de Vries, P C J I Schiele. Proteomics and Down syndrome screening: a validation study. Prenatal diagnosis. vol 30. issue 11. 2011-03-07. PMID:20827711. |
in a previous discovery study, we identified seven potential screening markers for down syndrome (ds). |
2011-03-07 |
2023-08-12 |
Not clear |
| Jerzy Wegiel, Wojciech Kaczmarski, Madhabi Barua, Izabela Kuchna, Krzysztof Nowicki, Kuo-Chiang Wang, Jarek Wegiel, Shuang Ma Yang, Janusz Frackowiak, Bozena Mazur-Kolecka, Wayne P Silverman, Barry Reisberg, Isabel Monteiro, Mony de Leon, Thomas Wisniewski, Arthur Dalton, Florence Lai, Yu-Wen Hwang, Tatyana Adayev, Fei Liu, Khalid Iqbal, Inge-Grundke Iqbal, Cheng-Xin Gon. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. Journal of neuropathology and experimental neurology. vol 70. issue 1. 2011-03-07. PMID:21157379. |
triplication of chromosome 21 in down syndrome (ds) results in overexpression of the minibrain kinase/dual-specificity tyrosine phosphorylated and regulated kinase 1a gene (dyrk1a). |
2011-03-07 |
2023-08-12 |
human |
| A Karama. Medical problems in children with Down syndrome in the Erzurum area of Turkey. Genetic counseling (Geneva, Switzerland). vol 21. issue 4. 2011-03-02. PMID:21290968. |
down syndrome (ds) is diagnosed in approximately 1 per 800 live births and is the most common known genetic cause of medical problems. |
2011-03-02 |
2023-08-12 |
Not clear |
| Dennis Rose. Some infants with Down syndrome spontaneously outgrow their obstructive sleep apnea. Clinical pediatrics. vol 49. issue 11. 2011-03-01. PMID:20724331. |
obstructive sleep apnea (osa) is commonly seen in children with down syndrome (ds). |
2011-03-01 |
2023-08-12 |
Not clear |